[Lys]9-VmCT1-NH2
General Information
DCTPep ID DCTPep02279
Peptide Name [Lys]9-VmCT1-NH2
Sequence FLGALWNVKKSVF
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Membrane lysis
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | >100 µM | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: ~0% Hemolytic>100 µM
Normal (non-cancerous) Cytotoxicity MCF-10A: Not active up to 25 μM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02279
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C75H113N17O16
Absent amino acids CDEHIMPQRTY
Theoretical pI 10.00
Acidic residues 0
Basic residues 2
Polar residues 3
Molecular weight (Average) 1508.83
Molecular weight (Monoisotopic) 1507.86
Common amino acids FKLV
Net charge 2
Instability index (II) 28.19
Aliphatic index 112.31
Grand average of hydropathicity (GRAVY) 0.769
Half Life
1.1 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 5500
Abs 0.1% (=1 g/l) 3.645
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31181304
Title The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1
Doi 10.1016/j.ejps.2019.06.006
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_16789